abstract |
The present invention relates to novel quinoxalinones which are inhibitors of protein kinase C. The invention further relates to formulations comprising said inhibitors of protein kinase C, use thereof in medical therapy and in the manufacture of a medicament for the treatment of inflammatory, immunological, bronchopulmonary, cardiovascular, oncological or CNS-degenerative disorders. |